# Ask what a clinic advertisement really promises *Arizona Joint Pain Clinic Reviews | Reading Clinic Advertising* > Arizona joint pain clinic reviews with direct questions about treatment ads, expected results, total cost, and other choices. Some mornings, the ache starts before the coffee is ready. An advertisement that promises an easy answer can sound good right then. But a polished message can't identify the cause of your soreness. It also can't say how your body will respond. I'd want the plain limits before I spent money or agreed to care. ## What to ask when an ad sounds certain Strip the ad down to plain questions. Start with what the treatment contains. Ask what change is expected and how long it might last. Who wasn't helped in the work behind the claim? Ask whether the answer is about your sore joint or a different problem. A personal account may be sincere, but it can't show why someone felt better. Neither can a clinic rating. Certain words need extra care. Natural doesn't mean risk-free. Modern doesn't mean well proven. Non-surgical doesn't mean right for every person. QC Kinetix offers regenerative treatments, meaning care prepared at a clinic with blood or tissue by licensed staff. That tells you what kind of option is discussed, not what result you'll have. Certainty in an ad isn't certainty about your joint. ## How to check cost and follow-up Ask for the full cost in writing before you pay. Find out what each charge covers and what happens if the plan changes. Insurance and medical value aren't the same question, so don't let either answer stand in for the other. Ask about risks, other choices, and the care you'll get if soreness grows. A good talk includes reasons not to use an option. Watch for pressure tied to a short offer or fear of surgery. You can pause. You can also take the information to the doctor or nurse who knows you. No public comment can settle the medical question for you, and no advertisement can remove all doubt. The plain answer may include uncertainty. ## Evidence sources 1. The FTC's Health Products Compliance Guidance sets out the standard every health claim in advertising must meet. Advertising must be truthful and not misleading, and before an ad runs the advertiser must hold adequate substantiation for every objective claim it conveys expressly or by implication. As a general rule, claims about the health benefits or safety of foods, dietary supplements, drugs and other health-related products require substantiation in the form of 'competent and reliable scientific evidence'. The guidance explicitly covers websites, social media, influencer marketing, press interviews, seminars, and claims made indirectly through healthcare practitioners. Federal Trade Commission, Bureau of Consumer Protection — [Health Products Compliance Guidance](https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance). *FTC Business Guidance*, 2022. 2. FDA states verbatim that of the products marketed as regenerative medicine - stem cell products, stromal vascular fraction from adipose tissue, umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products - 'None of these products have been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells from umbilical cord blood, approved only for disorders of blood production, and there are currently no FDA-approved exosome products. U.S. Food and Drug Administration — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA (Center for Biologics Evaluation and Research)*, 2024. 3. Medicare's national coverage policy states that CMS covers autologous platelet-rich plasma only for patients with chronic non-healing diabetic, pressure and/or venous wounds, and only inside an approved coverage-with-evidence-development clinical research study. There is no Medicare national coverage for PRP in osteoarthritis or any other joint indication, which is why these injections are billed to the patient as cash-pay. Centers for Medicare & Medicaid Services — [Autologous Platelet-rich Plasma (Coverage with Evidence Development)](https://www.cms.gov/medicare/coverage/evidence/plasma). *CMS.gov*, 2024. 4. A 2025 Cochrane living review of 25 randomised trials (1,341 participants) found that compared with placebo injection, stem cell injections for knee osteoarthritis MAY slightly improve pain and function up to six months, on LOW-certainty evidence: mean pain was 4.5 of 10 with placebo and 1.2 points better with stem cells; function 46.3 of 100 with placebo and 14.2 points better. Certainty was downgraded for indirectness (source, preparation and dose of cells varied across studies) and suspected publication bias - up to three larger trials were conducted and then withdrawn before reporting. Radiographic progression was not assessed in ANY included study, and the review remains uncertain about harms. Whittle SL, Johnston RV, McDonald S, et al. — [Stem cell injections for osteoarthritis of the knee.](https://pubmed.ncbi.nlm.nih.gov/40169165/). *Cochrane Database of Systematic Reviews*, 2025. 5. A meta-analysis of 198 randomised osteoarthritis trials (16,364 patients in placebo groups, 1,167 in untreated control groups) found the placebo arm itself relieved pain with an effect size of 0.51 (95% CI 0.46-0.55), against 0.03 (95% CI -0.13 to 0.18) in untreated controls. Placebo also improved function and stiffness. The placebo effect was larger when the active treatment effect was larger, when baseline pain was higher, and - relevant to any injected treatment - when the placebo was delivered by injection rather than by mouth. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M — [The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials.](https://pubmed.ncbi.nlm.nih.gov/18541604/). *Annals of the Rheumatic Diseases*, 2008. 6. In January 2025 the FTC and the Georgia Attorney General obtained federal court orders permanently banning the co-founders of the Stem Cell Institute of America and related companies from marketing stem cell therapy, plus $5,155,146 in civil penalties and consumer refunds. The court found on summary judgment that the defendants published false and misleading advertisements about the efficacy and approval of stem cell injections for conditions including osteoarthritis; the affiliated clinic had charged up to $5,000 per injection, almost exclusively to elderly and disabled consumers. Federal Trade Commission — [Stem Cell Institute Co-Founders and Companies Banned from Marketing Stem Cell Treatments and Ordered to Pay More Than $5.1 Million for Refunds and Civil Penalties](https://www.ftc.gov/news-events/news/press-releases/2025/01/stem-cell-institute-co-founders-companies-banned-marketing-stem-cell-treatments-ordered-pay-more-51). *FTC Press Release*, 2025. ## What to ask before you book There's no charge for the first conversation. Ask what the visit includes, what each option costs, and when another kind of care makes more sense. book a free consultation: --- What hurts, what may help, and when to get care. Clear talk about sore joints, public Google clinic reviews, and useful things to ask before you choose care. Plain help for sore joints, public Google reviews, and the questions to ask before care. Arizona Joint Care Ledger is operated by the owners of the QC Kinetix Phoenix-area clinics; those owners may benefit financially from bookings made through this site, and their clinic profiles can appear under the same source rule used for every included listing. The signed dataset supplies clinic identity, city, public aggregate fields, observation date, canonical source link, and deterministic order; authored prose supplies none of those facts. © 2026 Arizona Joint Care Ledger. Educational material is not personal medical advice.